Chemoradiotherapy for Patients With Oligometastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study tries to evaluate the role of chemoradiation with capecitabine and bevacizumab in
oligometastatic patients neither being progressive nor resectable after chemotherapy.